Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: presently (14)

Lynch syndrome - patient information

Description: This leaflet contains information about Lynch syndrome.
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Lynch-syndrome-1431-PIL.pdf

Follow up after breast cancer - patient information

Description: This booklet explains what self-supported management is after treatment for early breast cancer and how it works.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Follow-up-after-breast-cancer-1107-PIL.pdf

Spinal enhanced recovery programme - patient information

Description: This factsheet explains what the spinal enhanced recovery programme is and what to expect in the days before and after your
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Spinal-enhanced-recovery-programme-2966-PIL.pdf

Oesophageal manometry test and 24-hour pH and impedance measurement test - Patients off proton pump inhibitors (PPIs) - patient information

Description: This factsheet explains what an oesophageal manometry test and a 24-hour pH and impedance measurement test are and what they
Url: /Media/UHS-website-2019/Patientinformation/Tests/Oesophageal-manometry-test-and-24-hour-pH-and-impedance-measurement-test-Patients-off-proton-pump-inhibitors-PPIs-3729-PIL.pdf

Oesophageal manometry test and 24-hour pH and impedance measurement test - Patients on proton pump inhibitors (PPIs) - patient information

Description: This factsheet explains what an oesophageal manometry test and a 24-hour pH and impedance measurement test are and what they
Url: /Media/UHS-website-2019/Patientinformation/Tests/Oesophageal-manometry-test-and-24-hour-pH-and-impedance-measurement-test-Patients-on-proton-pump-inhibitors-PPIs-3728-PIL.pdf

Tarlatamab (EAMS)

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) Tarlatamab (EAMS) Regimen • SCLC – Tarlatamab (EAMS) Indication • Tarlatamab is indicat
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Tarlatamab-EAMS-Ver-1.0.pdf

Papers CoG - 29.01.2025

Description: Date Time Location Chair Agenda Council of Governors 29/01/2025 14:00 - 15:30 Conference Room, Heartbeat/Microsoft Teams Jenni Douglas-Tod
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-29.01.2025.pdf

Workforce Race Equality Standard annual report 2024

Description: Executive Summary WRES Data has been submitted by the Trust since 2015 and progress is reviewed against the nine indicators contained within the WRES das
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/UHS-WRES-report-2024.pdf

Carboplatin Paclitaxel EC Pembrolizumab Neoadjuvant Ver1.0

Description: Chemotherapy Protocol BREAST CANCER PEMBROLIZUMAB WITH CARBOPLATIN/PACLITAXEL AND EC NEOADJUVANT BREAST CANCER FOLLOWED BY ADJUVANT PEMBROLIZUMAB Reg
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Paclitaxel-EC-Pembrolizumab-Neoadjuvant.pdf

Uterine fibroid embolisation - patient information

Description: This factsheet explains what uterine fibroid embolisation is, what the procedure involves and what the possible risks are.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Uterine-fibroid-embolisation-3608-PIL.pdf

341 to 350 of 411

Previous … 33 34 35 36 37 … Next